WT1 and WT1‐AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma
暂无分享,去创建一个
Mukesh Verma | Rajvir Dahiya | Hiroaki Shiina | R. Dahiya | M. Kaneuchi | N. Sakuragi | Yuichiro Tanaka | H. Shiina | M. Verma | H. Enokida | R. Yamamoto | Yuichiro Tanaka | Hideki Enokida | M. Sasaki | Masanori Kaneuchi | Masahiro Sasaki | Hideto Yamada | Ritsu Yamamoto | Noriaki Sakuragi | Hideto Yamada | Y. Tanaka
[1] D. Lubahn,et al. Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique. , 1997, Cancer research.
[2] K. Malik,et al. The molecular biology of Wilms' tumour , 2001, Expert Reviews in Molecular Medicine.
[3] D. Lubahn,et al. Hypermethylation of the Wilms' tumor suppressor gene CpG island in human breast carcinomas , 1999, Breast Cancer Research and Treatment.
[4] M. McKay,et al. Cancer of the ovary. , 1994, The New England journal of medicine.
[5] D. Haber,et al. Wilms tumor and the WT1 gene. , 2001, Experimental cell research.
[6] I. Konishi,et al. Immunohistochemical Detection of the Wilms' Tumor Gene (WT1) in Epithelial Ovarian Tumors , 2000, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[7] C. B. Patel,et al. Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. , 2001, Cancer research.
[8] B. Williams,et al. Antisense transcripts and protein binding motifs within the Wilms tumour (WT1) locus. , 1994, Oncogene.
[9] Kathleen R. Cho,et al. Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. , 2002, Cancer research.
[10] S. Cannistra. Medical progress : cancer of the ovary , 1993 .
[11] Osamu Ogawa,et al. Cloning of novel Wilms tumor gene (WT1) cDNAs; evidence for antisense transcription of WT1. , 1994, Oncogene.
[12] W. Hofmann,et al. Characterization of the transcriptional regulatory region of the human WT1 gene. , 1993, Oncogene.
[13] K. Malik,et al. Identification of an antisense WT1 promoter in intron 1: implications for WT1 gene regulation. , 1995, Oncogene.
[14] C. Walker,et al. Identification of a tumor-specific methylation site in the Wilms tumor suppressor gene , 1998, Oncogene.
[15] R. Dahiya,et al. MULTIPLE PROMOTERS OF CATECHOL-O-METHYLTRANSFERASE GENE ARE SELECTIVELY INACTIVATED BY CPG HYPERMETHYLATION IN ENDOMETRIAL CANCER , 2003, International Journal of Gynecologic Cancer.
[16] V. Kosma,et al. Hypermethylation of the WT1 and calcitonin gene promoter regions at chromosome 11p in human colorectal cancer. , 1997, British Journal of Cancer.
[17] Trevor Hastie,et al. Gene expression patterns in ovarian carcinomas. , 2003, Molecular biology of the cell.
[18] M. Gessler,et al. Sequence of the WT1 upstream region including the Wit-1 gene. , 1993, Genomics.
[19] James B. Mitchell,et al. Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. , 2004, Cancer cell.
[20] A. Feinberg,et al. Tissue, developmental, and tumor-specific expression of divergent transcripts in Wilms tumor. , 1990, Science.